Miguel López‐Lázaro

7.9k total citations · 3 hit papers
98 papers, 5.8k citations indexed

About

Miguel López‐Lázaro is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Miguel López‐Lázaro has authored 98 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 18 papers in Cancer Research and 17 papers in Organic Chemistry. Recurrent topics in Miguel López‐Lázaro's work include Cancer therapeutics and mechanisms (18 papers), Bioactive Compounds and Antitumor Agents (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Miguel López‐Lázaro is often cited by papers focused on Cancer therapeutics and mechanisms (18 papers), Bioactive Compounds and Antitumor Agents (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Miguel López‐Lázaro collaborates with scholars based in Spain, United Kingdom and Sweden. Miguel López‐Lázaro's co-authors include José Manuel Calderón‐Montaño, Estefanía Burgos‐Morón, Concepción Pérez‐Guerrero, Carmen Martı́n-Cordero, Caroline A. Austin, Marı́a Jesús Ayuso, Nuria Pastor, Manuel Luís Orta, Elaine Willmore and Antonio J. León‐González and has published in prestigious journals such as Nucleic Acids Research, Journal of Agricultural and Food Chemistry and The FASEB Journal.

In The Last Decade

Miguel López‐Lázaro

95 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Review on the Dietary Flavonoid Kaempferol

2011 1.1k citations José Manuel Calderón‐Montaño, Estefanía Burgos‐Morón et al. profile →
Distribution and Biological Activities of the Flavonoid Luteolin

2008 905 citations Miguel López‐Lázaro profile →
Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy

2006 606 citations Miguel López‐Lázaro profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miguel López‐Lázaro Spain	34	2.8k	857	733	669	668	98	5.8k
Katrin Sak India	37	2.8k 1.0×	729 0.9×	734 1.0×	454 0.7×	608 0.9×	125	5.9k
Hardeep Singh Tuli India	43	3.3k 1.2×	897 1.0×	750 1.0×	631 0.9×	733 1.1×	253	7.3k
Xi Zheng China	42	2.9k 1.0×	683 0.8×	418 0.6×	572 0.9×	915 1.4×	203	6.5k
Saikat Dewanjee India	42	2.3k 0.8×	831 1.0×	416 0.6×	375 0.6×	389 0.6×	141	6.1k
Yi Chen China	37	2.3k 0.8×	729 0.9×	695 0.9×	287 0.4×	508 0.8×	151	5.5k
Imtiaz A. Siddiqui United States	50	2.6k 0.9×	455 0.5×	1.0k 1.4×	342 0.5×	538 0.8×	88	6.2k
Ramakrishna Sistla India	54	3.1k 1.1×	675 0.8×	346 0.5×	1.2k 1.7×	301 0.5×	189	8.1k
Carmela Fimognari Italy	38	2.6k 0.9×	771 0.9×	442 0.6×	710 1.1×	593 0.9×	145	5.0k
Azhar Rasul Pakistan	41	2.5k 0.9×	842 1.0×	388 0.5×	538 0.8×	622 0.9×	190	5.5k
Chris Beecher United States	30	3.4k 1.2×	855 1.0×	797 1.1×	510 0.8×	369 0.6×	66	6.4k

Countries citing papers authored by Miguel López‐Lázaro

Since Specialization

Citations

This map shows the geographic impact of Miguel López‐Lázaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel López‐Lázaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel López‐Lázaro more than expected).

Fields of papers citing papers by Miguel López‐Lázaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel López‐Lázaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel López‐Lázaro. The network helps show where Miguel López‐Lázaro may publish in the future.

Co-authorship network of co-authors of Miguel López‐Lázaro

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel López‐Lázaro. A scholar is included among the top collaborators of Miguel López‐Lázaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel López‐Lázaro. Miguel López‐Lázaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López‐Lázaro, Miguel. (2025). Misleading nomenclature in the IARC Monographs Programme: a straightforward solution to improve accuracy and clarity. Exploration of Medicine.

Calderón‐Montaño, José Manuel, Francisco Prieto, Miguel López‐Lázaro, et al.. (2024). A quality-by-design approach for optimizing the functionalization of gold nanoparticles onto the surface of doxorubicin-encapsulated liposomes. International Journal of Pharmaceutics. 669. 125040–125040. 5 indexed citations

Calderón‐Montaño, José Manuel, et al.. (2024). A Diet Lacking Selenium, but Not Zinc, Copper or Manganese, Induces Anticancer Activity in Mice with Metastatic Cancers. Nutrients. 16(14). 2249–2249.

Calderón‐Montaño, José Manuel, et al.. (2023). Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer. Cancers. 15(5). 1540–1540. 8 indexed citations

Calderón‐Montaño, José Manuel, et al.. (2023). Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma. International Journal of Molecular Sciences. 24(5). 4587–4587. 2 indexed citations

López‐Lázaro, Miguel, et al.. (2023). Dietary Manipulation of Amino Acids for Cancer Therapy. Nutrients. 15(13). 2879–2879. 12 indexed citations

Burgos‐Morón, Estefanía, Sarah Mazzotta, José Manuel Calderón‐Montaño, et al.. (2023). Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents—In Vitro Evaluation against Breast Cancer Cells. International Journal of Molecular Sciences. 24(23). 17041–17041. 2 indexed citations

Benítez, Guillermo, et al.. (2023). Evaluation of Anticancer Activity of 76 Plant Species Collected in Andalusia (Spain) against Lung Cancer Cells. Plants. 12(18). 3275–3275. 5 indexed citations

Calderón‐Montaño, José Manuel, et al.. (2022). Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer. Nutrients. 14(16). 3378–3378. 8 indexed citations

10.

Calderón‐Montaño, José Manuel, et al.. (2022). Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma. International Journal of Molecular Sciences. 23(24). 16132–16132. 9 indexed citations

11.

Calderón‐Montaño, José Manuel, Estefanía Burgos‐Morón, Miguel López‐Lázaro, et al.. (2021). Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity. Journal of Medicinal Chemistry. 64(14). 10350–10370. 18 indexed citations

12.

Burgos‐Morón, Estefanía, Nuria Pastor, Manuel Luís Orta, et al.. (2021). In Vitro Anticancer Activity and Mechanism of Action of an Aziridinyl Galactopyranoside. Biomedicines. 10(1). 41–41. 5 indexed citations

13.

García, Mónica Cristina, José Manuel Calderón‐Montaño, M. Rueda, et al.. (2021). Cholesterol Levels Affect the Performance of AuNPs-Decorated Thermo-Sensitive Liposomes as Nanocarriers for Controlled Doxorubicin Delivery. Pharmaceutics. 13(7). 973–973. 16 indexed citations

14.

Calderón‐Montaño, José Manuel, et al.. (2021). Screening for Selective Anticancer Activity of 65 Extracts of Plants Collected in Western Andalusia, Spain. Plants. 10(10). 2193–2193. 38 indexed citations

15.

Zbakh, Hanaâ, Eva Zubı́a, Carolina de los Reyes, et al.. (2020). Meroterpenoids from the Brown Alga Cystoseira usneoides as Potential Anti-Inflammatory and Lung Anticancer Agents. Marine Drugs. 18(4). 207–207. 22 indexed citations

16.

Burgos‐Morón, Estefanía, Nuria Pastor, Manuel Luís Orta, et al.. (2018). Selective cytotoxic activity and DNA damage by an epoxyalkyl galactopyranoside. Drug Development Research. 79(8). 426–436. 2 indexed citations

17.

López‐Lázaro, Miguel, et al.. (2016). What Is The Main Cause Of Cancer?. 1(1). 2 indexed citations

18.

Orta, Manuel Luís, Andreas Höglund, José Manuel Calderón‐Montaño, et al.. (2014). The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions. Nucleic Acids Research. 42(14). 9108–9120. 71 indexed citations

19.

Gálvez, María Elena, et al.. (2011). Citotoxicidad de plantago major L.. Acceda (Universidad de Las Palmas de Gran Canaria).

20.

Berrougui, Hicham, et al.. (2005). Cytotoxic activity of methanolic extract and two alkaloids extracted from seeds of Peganum harmala L.. Journal of Natural Remedies. 5(1). 41–45. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact